Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neutral antagonism at the cannabinoid 1 receptor: a safer treatment for obesity
Frank J. Meye, Viviana Trezza, Louk J. M. J. Vanderschuren, et al.
Molecular Psychiatry (2012) Vol. 18, Iss. 12, pp. 1294-1301
Open Access | Times Cited: 76

Showing 1-25 of 76 citing articles:

Signaling pathways in obesity: mechanisms and therapeutic interventions
Xue Wen, Bohan Zhang, Beiyi Wu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 250
Amygdala FAAH and anandamide: mediating protection and recovery from stress
Ozge Gunduz‐Cinar, Matthew N. Hill, Bruce S. McEwen, et al.
Trends in Pharmacological Sciences (2013) Vol. 34, Iss. 11, pp. 637-644
Open Access | Times Cited: 210
The Endocannabinoid System: A Potential Target for the Treatment of Various Diseases
Henry Lowe, Ngeh J. Toyang, Blair Steele, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 17, pp. 9472-9472
Open Access | Times Cited: 206
Obesity: Current and potential pharmacotherapeutics and targets
Vidya Narayanaswami, Linda P. Dwoskin
Pharmacology & Therapeutics (2016) Vol. 170, pp. 116-147
Open Access | Times Cited: 171
Anti-Obesity Therapy: from Rainbow Pills to Polyagonists
Timo D. Müller, Christoffer Clemmensen, Brian Finan, et al.
Pharmacological Reviews (2018) Vol. 70, Iss. 4, pp. 712-746
Open Access | Times Cited: 163
Endocannabinoid system and mood disorders: Priming a target for new therapies
Vincenzo Micale, Vincenzo Di Marzo, Alexandra Šulcová, et al.
Pharmacology & Therapeutics (2012) Vol. 138, Iss. 1, pp. 18-37
Closed Access | Times Cited: 205
Feelings about food: the ventral tegmental area in food reward and emotional eating
Frank J. Meye, Roger A.H. Adan
Trends in Pharmacological Sciences (2013) Vol. 35, Iss. 1, pp. 31-40
Closed Access | Times Cited: 141
Multiple Forms of Endocannabinoid and Endovanilloid Signaling Regulate the Tonic Control of GABA Release
Sang‐Hoon Lee, Marco Ledri, Blanka Tóth, et al.
Journal of Neuroscience (2015) Vol. 35, Iss. 27, pp. 10039-10057
Open Access | Times Cited: 128
Therapeutic potential of cannabinoid medicines
Philip Robson
Drug Testing and Analysis (2013) Vol. 6, Iss. 1-2, pp. 24-30
Closed Access | Times Cited: 117
A Guide to Targeting the Endocannabinoid System in Drug Design
Adam Stasiulewicz, Katarzyna Znajdek, Monika Grudzień, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 8, pp. 2778-2778
Open Access | Times Cited: 104
Cannabinoid Receptors: An Update on Cell Signaling, Pathophysiological Roles and Therapeutic Opportunities in Neurological, Cardiovascular, and Inflammatory Diseases
Dhanush Haspula, Michelle A. Clark
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 20, pp. 7693-7693
Open Access | Times Cited: 103
Mechanisms underlying current and future anti-obesity drugs
Roger A.H. Adan
Trends in Neurosciences (2013) Vol. 36, Iss. 2, pp. 133-140
Open Access | Times Cited: 102
MECHANISMS IN ENDOCRINOLOGY: Endocannabinoids and metabolism: past, present and future
Vincent Simon, Daniela Cota
European Journal of Endocrinology (2017) Vol. 176, Iss. 6, pp. R309-R324
Open Access | Times Cited: 100
Endocannabinoid modulation of homeostatic and non-homeostatic feeding circuits
Benjamin K. Lau, Daniela Cota, Luigia Cristino, et al.
Neuropharmacology (2017) Vol. 124, pp. 38-51
Closed Access | Times Cited: 93
New insights on the role of the endocannabinoid system in the regulation of energy balance
Blandine Gatta-Chérifi, Daniela Cota
International Journal of Obesity (2015) Vol. 40, Iss. 2, pp. 210-219
Open Access | Times Cited: 88
Cannabis: A Treasure Trove or Pandora's Box?
Katalin Solymosi, Attila Köfalvi
Mini-Reviews in Medicinal Chemistry (2016) Vol. 17, Iss. 13
Open Access | Times Cited: 85
The endocannabinoid system as a target for addiction treatment: Trials and tribulations
Matthew E. Sloan, Joshua L. Gowin, Vijay A. Ramchandani, et al.
Neuropharmacology (2017) Vol. 124, pp. 73-83
Closed Access | Times Cited: 85
Genetically reduced FAAH activity may be a risk for the development of anxiety and depression in persons with repetitive childhood trauma
Judit Lazáry, Nóra Eszlári, Gabriella Juhász, et al.
European Neuropsychopharmacology (2016) Vol. 26, Iss. 6, pp. 1020-1028
Open Access | Times Cited: 75
The CB1Neutral Antagonist AM4113 Retains the Therapeutic Efficacy of the Inverse Agonist Rimonabant for Nicotine Dependence and Weight Loss with Better Psychiatric Tolerability
Aliou B. Gueye, Yaroslaw Pryslawsky, José Trigo, et al.
The International Journal of Neuropsychopharmacology (2016) Vol. 19, Iss. 12, pp. pyw068-pyw068
Open Access | Times Cited: 69
Blockade of Nicotine and Cannabinoid Reinforcement and Relapse by a Cannabinoid CB1-Receptor Neutral Antagonist AM4113 and Inverse Agonist Rimonabant in Squirrel Monkeys
Charles W. Schindler, Godfrey H. Redhi, Kiran Vemuri, et al.
Neuropsychopharmacology (2016) Vol. 41, Iss. 9, pp. 2283-2293
Open Access | Times Cited: 65
Endocannabinoids and Mental Disorders
Tiziana Rubino, Erica Zamberletti, Daniela Parolaro
Handbook of experimental pharmacology (2015), pp. 261-283
Closed Access | Times Cited: 63
Cannabinoids in health and disease: pharmacological potential in metabolic syndrome and neuroinflammation
Andrea Mastinu, Marika Premoli, Giulia Ferrari‐Toninelli, et al.
Hormone Molecular Biology and Clinical Investigation (2018) Vol. 36, Iss. 2
Open Access | Times Cited: 58
Neural Effects of Cannabinoid CB1 Neutral Antagonist Tetrahydrocannabivarin on Food Reward and Aversion in Healthy Volunteers
Luke Tudge, Clare Williams, Philip J. Cowen, et al.
The International Journal of Neuropsychopharmacology (2015) Vol. 18, Iss. 6
Open Access | Times Cited: 53
Seventeen years since rimonabant's downfall: reassessing its suicidality risk profile
Yuval Cohen, Andrew Kolodziej, Marshall Morningstar
Obesity (2024) Vol. 32, Iss. 7, pp. 1235-1244
Open Access | Times Cited: 6
Targeting the Endocannabinoid/CB1 Receptor System For Treating Major Depression Through Antidepressant Activities of Curcumin and Dexanabinol-Loaded Solid Lipid Nanoparticles
Xiaolie He, Yang Li, Mei Wang, et al.
Cellular Physiology and Biochemistry (2017) Vol. 42, Iss. 6, pp. 2281-2294
Open Access | Times Cited: 48
Page 1 - Next Page

Scroll to top